Peginterferon-α-2a + ribavirin: shorter treatment duration inferior in hepatitis C

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1597, 2007-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peginterferon-α_2a in the treatment of chronic hepatitis C

By Akimov Sergey Adeyemi Oluwatoyin M

Future Virology, Vol. 1, Iss. 6, 2006-11 ,pp. : 689-701

Future Medicine

Access to resources Recommend Favorite

Peginterferon-α-2b + ribavirin for hep C during methadone treatment

Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Peginterferon-α_2a for the treatment of hepatitis B infection

By Cooksley W Graham E

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 8, 2005-07 ,pp. : 1373-1380

Informa Healthcare

Access to resources Recommend Favorite

Peginterferon-α-2b/ribavirin: Autoimmune hepatitis: case report

Reactions Weekly, Vol. 1, Iss. 1204, 2008-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

Pegylated Interferons for the Treatment of Chronic Hepatitis C: Pharmacological and Clinical Differences between Peginterferon-α-2a and Peginterferon-α-2b

By Foster Graham R.

Drugs, Vol. 70, Iss. 2, 2010-01 ,pp. : 147-165

Adis International

Access to resources Recommend Favorite